Production of human/mouse hybridomas secreting a human lymphokine, osteoclast activating factor.
A human/mouse hybridoma was developed which has the property of secreting a human bone resorbing factor similar or identical to the osteoclast activating factor (OAF) isolated from human tonsil lymphocytes. Mouse plasmacytoma cells negative for OAF production were fused with an enriched subpopulation of human tonsil lymphocytes that had been activated with phytohemagglutinin (PHA) to produce OAF (G.E. Nedwin, M.A. Mohler, and R.A. Luben, submitted for publication). Culture supernatants from mixed hybridomas contained a bone resorbing protein shown to cause the release of 45Ca from previously labeled mouse calvaria. The bone resorbing activity from these hybridomas was inhibited by the presence of OAF-specific monoclonal antibodies. Several hybridomas retained OAF production following limited dilution cloning. One clone, CD6.20, showed a biphasic dose-response curve for bone resorption similar to that of purified OAF from PHA-activated human tonsil lymphocytes. OAF production in the CD6.20 cell line has been retained for over 100 passages. Karyotype analysis of this cell shows the presence of human chromosomes 10 and 18 and the X chromosome.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000502:physiology; D001667:Binding, Competitive; D001862:Bone Resorption; D002460:Cell Line; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D006825:Hybridomas / Q000276:immunology*; D007158:Immunologic Techniques; D008222:Lymphokines / Q000096:biosynthesis* / Q000276:immunology / Q000502:physiology; D051379:Mice; D008807:Mice, Inbred BALB C; D010010:Osteoclasts / Q000502:physiology*
D000911:Antibodies, Monoclonal; D008222:Lymphokines; C008718:osteoclast activating factor